KWF Kankerbestrijding
Aljosja Karpenko possesses extensive experience in market access and strategy within the pharmaceutical field, currently serving as Strateeg geneesmiddelen at KWF Kankerbestrijding since February 2023. Prior positions include Market Access Manager at Bayer Pharmaceuticals and IQVIA Nederland, along with a role as a Board Member for JongBayer. Aljosja has contributed to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) by organizing masterclasses and seminars. Additional experience encompasses roles as a Business Analyst at Nederlandse Farmaceutische Zorggroep, Research Associate at Medstone, and Research Scholar at both The University of Manchester and Syreon Research Institute. Academic qualifications include a Master of Science in Farmacie from Utrecht University and a Master of Science in Health Economics, Policy & Law from Erasmus University Rotterdam.
This person is not in the org chart
KWF Kankerbestrijding
Every person in the Netherlands will at some stage have an experience with cancer When you have cancer, it disrupts your life, but also when someone you know has the disease. The consequences are overwhelming. To all those millions of lives, every day we can make the difference, successfully, for more than 71 years. We not only fight this disease, but we also strive for a better life living with cancer. We work on life-changing research and make sure that expensive medicines are available quickly to everyone. From approachable open houses to the safe community kanker.nl making sure we can support everyone who is living with cancer. And by mobilising the whole of the Netherlands for our joint mission. To make sure fewer people get cancer, more people are cured and more people live better with and after cancer. Simply because there’s so much to live for. DCS. Against cancer. For life.